TrialEuropean journal of clinical pharmacology2025

Pharmacogenomic, pharmacokinetic, and safety analysis of CYP3A4/CYP3A5 polymorphisms of midostaurin in patients with acute myeloid leukemia.

Romain Sechaud et al.PubMed ↗Publisher ↗

No numbers read from the abstract.